Related Experiment Video
Updated: Nov 8, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
Fluorescence artifact correction in the thrombin generation assay: Necessity for correction algorithms in
William C Chang1, Joseph W Jackson1, Kellie R Machlus2,3,4
1Office of Tissues and Advanced Therapies Center for Biologics Evaluation and Research US Food and Drug Administration Silver Spring MD USA.
Corrections for fluorogenic substrate depletion and inner filter effects are critical for detecting extremely procoagulant samples, like elevated prothrombin, using thrombin generation (TG) assays. Other conditions may not require these specific TG assay corrections.
Area of Science:
- Hemostasis and Thrombosis Research
- Biochemical Assays and Diagnostics
- Clinical Pathology
Background:
- Thrombin generation (TG) assays measure blood clotting but can underestimate hypercoagulability.
- Substrate depletion and inner filter effects (IFE) can cause inaccuracies in TG assays.
Purpose of the Study:
- To determine the necessity of correcting for substrate depletion and IFE in TG assays.
- To evaluate the impact of these corrections on TG parameters under various procoagulant conditions.
Main Methods:
- Analysis of TG parameters using a calibrated automated thrombogram (CAT) platform and in-house software.
- Evaluation in plasma with elevated coagulation factors (I, V, VIII, IX, X, XI) or prothrombin, with/without thrombomodulin.
- Assessment of artifact correction for substrate depletion and IFE.
Main Results:
- Elevated thrombin peak height (TPH) and endogenous thrombin potential (ETP) were observed with increased coagulation factors.
- The CAT algorithm's correction was minimal (<10%) for most elevated factors, not affecting procoagulant sample detection.
- For elevated prothrombin, uncorrected TG values were underestimated, while CAT correction significantly increased TG curves.
Conclusions:
- Correction for substrate consumption and IFE is crucial for identifying specific hypercoagulable states, particularly elevated prothrombin.
- These corrections are not universally required for all procoagulant conditions, such as elevated factors XI and VIII.
More Related Videos
06:16Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017